A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
Our aim was to investigate the effects of antivascular endothelial growth factor (anti-VEGF) antibody Bevacizumab on endometrial explants and on apoptotic gene expression levels in the rat endometriosis model. Endometriotic implants were surgically formed, and rats treated with (i) 1 mg/kg single su...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2014-12-01
|
Series: | Balkan Journal of Medical Genetics |
Subjects: | |
Online Access: | https://doi.org/10.2478/bjmg-2014-0077 |
id |
doaj-b49f210a36284fc8afb4c606c363edf1 |
---|---|
record_format |
Article |
spelling |
doaj-b49f210a36284fc8afb4c606c363edf12021-09-05T21:00:30ZengSciendoBalkan Journal of Medical Genetics1311-01602014-12-01172738010.2478/bjmg-2014-0077bjmg-2014-0077A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis ModelSoysal D.0Kızıldağ S.1Saatlı B.2Posacı C.3Soysal S.4Koyuncuoğlu M.5Doğan Ö. E.6Dokuz Eylül University, Obstetrics and Gynecology, 35340, İzmir, TurkeySefa Kızıldağ, Ph.D., Dokuz Eylül University, Faculty of Medicine, 35340 İnciralti, İzmir, Turkey. Tel.: +90-2324124613. Fax: +90-2322590541Dokuz Eylül University, Obstetrics and Gynecology, 35340, İzmir, TurkeyDokuz Eylül University, Obstetrics and Gynecology, 35340, İzmir, TurkeyMenemen State Hospital, Obstetrics and Gynecology, 35660, İzmir, TurkeyDokuz Eylül University, Pathology, 35340, İzmir, TurkeyDokuz Eylül University, Obstetrics and Gynecology, 35340, İzmir, TurkeyOur aim was to investigate the effects of antivascular endothelial growth factor (anti-VEGF) antibody Bevacizumab on endometrial explants and on apoptotic gene expression levels in the rat endometriosis model. Endometriotic implants were surgically formed, and rats treated with (i) 1 mg/kg single subcutaneous injection of depot leuprolide acetate; (ii) 2.5 mg/kg of single intaperitoneal injection of bevacizumab; (iii) intraperitoneal injection of saline. Histopathologic scores and adhesion scores of endometriotic foci and levels of Bcl-2-associated X protein (Bax), Cytochrome c (Cyt-c), B-cell lymphoma/ leukemia 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-xl) mRNA gene expressions of endometriotic foci. Bevacizumab treatment decreased the endometriotic explant size compared with control. Bevacizumab-treated rats had lower total adhesion scores when compared with the control group. Semiquantitative evaluation of the persistence of endometrial epithelial cells in the explants showed a lower score in gonadotropin-releasing hormone (GnRH) agonist-treated rats compared with control rats. In Bevacizumab increased expression of Bax 3.1-fold, Cyt-c 1.3-fold and decreased expression of Bcl-2 0.4-fold, Bcl-xl 0.8-fold compared with the control group. The GnRH agonist increased expression of Bax 3.0 fold, Cyt-c 1.3 fold and decreased expression of Bcl-2 0.4-fold, Bcl-xl 0.8-fold, compared with the control group. This study suggests that a novel angiogenesis inhibitor, anti-VEGF antibody bevacizumab is as effective as GnRH agonist in the regression of the endometriotic lesions in rat endometriosis model. One possible mechanism of this effect is the induction of apoptosis.https://doi.org/10.2478/bjmg-2014-0077endometriosisapoptosisbevacizumabangiogenesis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Soysal D. Kızıldağ S. Saatlı B. Posacı C. Soysal S. Koyuncuoğlu M. Doğan Ö. E. |
spellingShingle |
Soysal D. Kızıldağ S. Saatlı B. Posacı C. Soysal S. Koyuncuoğlu M. Doğan Ö. E. A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model Balkan Journal of Medical Genetics endometriosis apoptosis bevacizumab angiogenesis |
author_facet |
Soysal D. Kızıldağ S. Saatlı B. Posacı C. Soysal S. Koyuncuoğlu M. Doğan Ö. E. |
author_sort |
Soysal D. |
title |
A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model |
title_short |
A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model |
title_full |
A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model |
title_fullStr |
A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model |
title_full_unstemmed |
A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model |
title_sort |
novel angiogenesis inhibitor bevacizumab induces apoptosis in the rat endometriosis model |
publisher |
Sciendo |
series |
Balkan Journal of Medical Genetics |
issn |
1311-0160 |
publishDate |
2014-12-01 |
description |
Our aim was to investigate the effects of antivascular endothelial growth factor (anti-VEGF) antibody Bevacizumab on endometrial explants and on apoptotic gene expression levels in the rat endometriosis model. Endometriotic implants were surgically formed, and rats treated with (i) 1 mg/kg single subcutaneous injection of depot leuprolide acetate; (ii) 2.5 mg/kg of single intaperitoneal injection of bevacizumab; (iii) intraperitoneal injection of saline. Histopathologic scores and adhesion scores of endometriotic foci and levels of Bcl-2-associated X protein (Bax), Cytochrome c (Cyt-c), B-cell lymphoma/ leukemia 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-xl) mRNA gene expressions of endometriotic foci. Bevacizumab treatment decreased the endometriotic explant size compared with control. Bevacizumab-treated rats had lower total adhesion scores when compared with the control group. Semiquantitative evaluation of the persistence of endometrial epithelial cells in the explants showed a lower score in gonadotropin-releasing hormone (GnRH) agonist-treated rats compared with control rats. In Bevacizumab increased expression of Bax 3.1-fold, Cyt-c 1.3-fold and decreased expression of Bcl-2 0.4-fold, Bcl-xl 0.8-fold compared with the control group. The GnRH agonist increased expression of Bax 3.0 fold, Cyt-c 1.3 fold and decreased expression of Bcl-2 0.4-fold, Bcl-xl 0.8-fold, compared with the control group. This study suggests that a novel angiogenesis inhibitor, anti-VEGF antibody bevacizumab is as effective as GnRH agonist in the regression of the endometriotic lesions in rat endometriosis model. One possible mechanism of this effect is the induction of apoptosis. |
topic |
endometriosis apoptosis bevacizumab angiogenesis |
url |
https://doi.org/10.2478/bjmg-2014-0077 |
work_keys_str_mv |
AT soysald anovelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT kızıldags anovelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT saatlıb anovelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT posacıc anovelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT soysals anovelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT koyuncuoglum anovelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT doganoe anovelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT soysald novelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT kızıldags novelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT saatlıb novelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT posacıc novelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT soysals novelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT koyuncuoglum novelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel AT doganoe novelangiogenesisinhibitorbevacizumabinducesapoptosisintheratendometriosismodel |
_version_ |
1717782790607470592 |